389 related articles for article (PubMed ID: 11115831)
1. Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development.
Benvegnù L; Noventa F; Bernardinello E; Pontisso P; Gatta A; Alberti A
Gut; 2001 Jan; 48(1):110-5. PubMed ID: 11115831
[TBL] [Abstract][Full Text] [Related]
2. Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis.
Benvegnù L; Alberti A
Antiviral Res; 2001 Nov; 52(2):199-207. PubMed ID: 11672830
[TBL] [Abstract][Full Text] [Related]
3. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
4. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
[TBL] [Abstract][Full Text] [Related]
5. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
6. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
[TBL] [Abstract][Full Text] [Related]
7. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
Chiba T; Matsuzaki Y; Abei M; Shoda J; Tanaka N; Osuga T; Aikawa T
Am J Gastroenterol; 1996 Jun; 91(6):1195-203. PubMed ID: 8651170
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
[TBL] [Abstract][Full Text] [Related]
9. Patients with ultrasonic coarse-nodular cirrhosis who are anti-hepatitis C virus-positive are at high risk for hepatocellular carcinoma.
Tarao K; Hoshino H; Shimizu A; Ohkawa S; Harada M; Nakamura Y; Ito Y; Tamai S; Okamoto N
Cancer; 1995 Mar; 75(6):1255-62. PubMed ID: 7533653
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers.
Yu MW; Hsu FC; Sheen IS; Chu CM; Lin DY; Chen CJ; Liaw YF
Am J Epidemiol; 1997 Jun; 145(11):1039-47. PubMed ID: 9169913
[TBL] [Abstract][Full Text] [Related]
11. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
12. Improved detection of hepatocellular carcinoma by dynamic computed tomography in cirrhotic patients with chronic hepatitis B: A multicenter study.
Kim JH; Kang SH; Lee M; Choi HS; Jun BG; Kim TS; Choi DH; Suk KT; Kim MY; Kim YD; Cheon GJ; Baik SK; Kim DJ
J Gastroenterol Hepatol; 2020 Oct; 35(10):1795-1803. PubMed ID: 32222111
[TBL] [Abstract][Full Text] [Related]
13. Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis.
Tarao K; Rino Y; Ohkawa S; Tamai S; Miyakawa K; Takakura H; Endo O; Yoshitsugu M; Watanabe N; Matsuzaki S
Cancer; 2002 Mar; 94(6):1787-95. PubMed ID: 11920542
[TBL] [Abstract][Full Text] [Related]
14. Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort.
Brichler S; Nahon P; Zoulim F; Layese R; Bourcier V; Audureau E; Sutton A; Letouze E; Cagnot C; Marcellin P; Guyader D; Roulot D; Pol S; de Ledinghen V; Zarski JP; Calès P; Tran A; Peron JM; Mallat A; Riachi G; Grange JD; Blanc JF; Bacq Y; Ouzan D; Bronowicki JP; Mathurin P; Larrey D; Alric L; Attali P; Serfaty L; Pilette C; Bourlière M; Thabut D; Silvain C; Wartelle C; Zucman D; Christidis C; Roudot-Thoraval F; Ganne-Carrie N;
J Viral Hepat; 2019 Mar; 26(3):384-396. PubMed ID: 30380181
[TBL] [Abstract][Full Text] [Related]
15. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis.
Kobayashi M; Ikeda K; Hosaka T; Sezaki H; Someya T; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
Cancer; 2006 Feb; 106(3):636-47. PubMed ID: 16369988
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.
Chen TH; Chen CJ; Yen MF; Lu SN; Sun CA; Huang GT; Yang PM; Lee HS; Duffy SW
Int J Cancer; 2002 Mar; 98(2):257-61. PubMed ID: 11857416
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.
Fasani P; Sangiovanni A; De Fazio C; Borzio M; Bruno S; Ronchi G; Del Ninno E; Colombo M
Hepatology; 1999 Jun; 29(6):1704-7. PubMed ID: 10347111
[TBL] [Abstract][Full Text] [Related]
19. The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen.
Innes H; Barclay ST; Hayes PC; Fraser A; Dillon JF; Stanley A; Bathgate A; McDonald SA; Goldberg D; Valerio H; Fox R; Kennedy N; Bramley P; Hutchinson SJ
J Hepatol; 2018 Apr; 68(4):646-654. PubMed ID: 29155019
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle fat deposition is associated with hepatocellular carcinoma development in patients with chronic liver disease.
Tachi Y; Kozuka A; Hirai T; Kojima Y; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H
Nutrition; 2018 Oct; 54():83-88. PubMed ID: 29753174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
